SmartTab Completes Gastric Environment Validation Study for InjectTab™ Platform

By Sacha Heppell - March 15, 2022

What if you were able to simply take a pill to receive the medication you’re used to receiving through a shot, like insulin? As a leading innovator and disruptive drug delivery company, SmartTab is driving the future of drug delivery to places people would have never expected it to go and injections with a conventional syringe and needle will soon be a thing of the past.  

SmartTab's InjectTab™ Oral Biologic Delivery System is a capsule for delivery of liquid small and large molecule drugs and biologics which are typically administered via self-injection. The platform can integrate wireless two way communication capabilities to transmit key monitoring data post-delivery related to drug efficacy collected through the capsule onboard sensors within the body system to a HIPAA compliant, encrypted database for the patient and health provider to monitor each dose in real-time. SmartTab has the potential to deliver medicines more effectively during clinical trials and advance patient care delivery while reducing healthcare costs. The company is on a mission to bring patient-centered drug delivery and monitoring to the 21st century to advance clinical trials—right here, right now.

SmartTab recently completed a Gastric Environment Validation Process in the lab that demonstrates the InjectTab™ capsule functioning in a beaker as the team prepares for preclinical studies studies in the coming months. Watch the video below to learn more.

 

 


Who Would Have Thought Podcast

WHO WOULD HAVE THOUGHT

Listen and Subscribe to the Podcast

The perspectives of digital health thought leaders today and an inquiry into digital technologies of tomorrow.

Listen Now